DAFNA Capital Management LLC 13F holdings, Q3 2025
Holdings as of September 30, 2025 · filings on SEC EDGAR · latest filing →
DAFNA Capital Management LLC disclosed 75 US equity positions worth $404.8m in its Q3 2025 13F filing. The largest position was STXS at 10.5% of the reported book, followed by XBI and RVMD. Against the Q2 2025 filing, it opened 2 new positions, added to 9 and reduced 16 among the top 50 holdings.
What did DAFNA Capital Management LLC own in Q3 2025? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q2 2025 |
|---|---|---|---|---|---|---|---|
| 1 | STXS STEREOTAXIS INC | 10.5% | $42.5m | 13,680,554 | 0% | held | |
| 2 | XBI SPDR S&P BIOTECH ETF | 9.9% | $40.2m | 401,505 | -3% | reduced | |
| 3 | RVMD REVOLUTION MEDICINES INC | Healthcare | 7.6% | $30.7m | 657,176 | -3% | reduced |
| 4 | CYTK CYTOKINETICS INC | Healthcare | 5.4% | $21.7m | 394,940 | -1% | reduced |
| 5 | ATRC ATRICURE INC | Healthcare | 5.2% | $20.9m | 592,273 | 0% | held |
| 6 | MERUS BV | 5.1% | $20.8m | 220,451 | -45% | reduced | |
| 7 | IBB ISHARES NASDAQ BIOTECH INDX | 3.7% | $14.8m | 102,500 | 0% | held | |
| 8 | IDYA IDEAYA BIOSCIENCES INC | Healthcare | 3.6% | $14.7m | 539,923 | -13% | reduced |
| 9 | AXGN AXOGEN INC | Healthcare | 3.3% | $13.2m | 742,282 | 0% | held |
| 10 | XENE XENON PHARMACEUTICALS INC | Healthcare | 2.9% | $11.6m | 287,939 | 0% | held |
| 11 | NBIX NEUROCRINE BIOSCIENCES INC | Healthcare | 2.4% | $9.9m | 70,615 | 0% | held |
| 12 | RCUS ARCUS BIOSCIENCES INC | Healthcare | 2.1% | $8.5m | 627,626 | 0% | held |
| 13 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 1.9% | $7.7m | 500,702 | -8% | reduced |
| 14 | DAWNGBX DAY ONE BIOPHARMACEUTICALS I | 1.7% | $7.0m | 999,163 | 14% | added | |
| 15 | ASND ASCENDIS PHARMA A/S | Healthcare | 1.6% | $6.6m | 33,177 | -54% | reduced |
| 16 | ASND ASCENDIS PHARMA A/S | 1.3% | $5.4m | 4,000,000 | 0% | held | |
| 17 | 4XC1 KALVISTA PHARMACEUTICALS INC | 1.3% | $5.1m | 422,731 | -27% | reduced | |
| 18 | BCAX BICARA THERAPEUTICS INC | 1.2% | $5.0m | 317,001 | 0% | held | |
| 19 | INGN INOGEN INC | Healthcare | 1.2% | $4.9m | 605,625 | 0% | held |
| 20 | CMPS COMPASS PATHWAYS PLC | Healthcare | 1.1% | $4.6m | 811,046 | 0% | held |
| 21 | LKFT GALAPAGOS NV | Healthcare | 1.1% | $4.5m | 130,175 | 0% | held |
| 22 | DXCM DEXCOM INC | Healthcare | 1.1% | $4.4m | 65,552 | 0% | held |
| 23 | TNDM TANDEM DIABETES CARE INC | Healthcare | 1.1% | $4.3m | 355,208 | 21% | added |
| 24 | KURA KURA ONCOLOGY INC | Healthcare | 1.0% | $4.1m | 463,368 | 0% | held |
| 25 | ALKS ALKERMES PLC | Healthcare | 1.0% | $4.0m | 134,748 | 30% | added |
| 26 | STOK STOKE THERAPEUTICS INC | Healthcare | 1.0% | $4.0m | 169,791 | -66% | reduced |
| 27 | SLNOEUR SOLENO THERAPEUTICS INC | 0.9% | $3.6m | 53,000 | – | new | |
| 28 | BHVN BIOHAVEN LTD | Healthcare | 0.9% | $3.5m | 235,235 | 0% | held |
| 29 | EWTX EDGEWISE THERAPEUTICS INC | 0.9% | $3.5m | 213,736 | -10% | reduced | |
| 30 | PROQR THERAPEUTICS N V | 0.8% | $3.3m | 1,567,561 | 0% | held | |
| 31 | LRMR LARIMAR THERAPEUTICS INC | Healthcare | 0.8% | $3.3m | 1,027,764 | 177% | added |
| 32 | CMPX COMPASS THERAPEUTICS INC | 0.8% | $3.3m | 946,661 | 80% | added | |
| 33 | MLYS MINERALYS THERAPEUTICS INC | Healthcare | 0.8% | $3.2m | 83,490 | -78% | reduced |
| 34 | NKTR NEKTAR THERAPEUTICS | Healthcare | 0.8% | $3.1m | 54,998 | 450% | added |
| 35 | IMVT IMMUNOVANT INC | Healthcare | 0.8% | $3.1m | 191,493 | 0% | held |
| 36 | KRRO KORRO BIO INC | Healthcare | 0.7% | $2.9m | 60,804 | 5% | added |
| 37 | AQST AQUESTIVE THERAPEUTICS INC | 0.7% | $2.9m | 512,589 | 261% | added | |
| 38 | DNLI DENALI THERAPEUTICS INC | Healthcare | 0.6% | $2.4m | 168,500 | 0% | held |
| 39 | LXEO LEXEO THERAPEUTICS INC | Healthcare | 0.6% | $2.4m | 358,083 | -5% | reduced |
| 40 | ALEC ALECTOR INC | Healthcare | 0.6% | $2.4m | 798,351 | -13% | reduced |
| 41 | CATBUSD ASTRIA THERAPEUTICS INC | 0.6% | $2.3m | 319,775 | -2% | reduced | |
| 42 | RAPP RAPPORT THERAPEUTICS INC | 0.6% | $2.2m | 75,000 | – | new | |
| 43 | TELA TELA BIO INC | 0.5% | $2.1m | 1,441,029 | 0% | held | |
| 44 | PODD INSULET CORP | Healthcare | 0.5% | $2.1m | 6,870 | -31% | reduced |
| 45 | MDWD MEDIWOUND LTD | Healthcare | 0.5% | $2.0m | 113,612 | 76% | added |
| 46 | ARAY ACCURAY INC | Healthcare | 0.5% | $2.0m | 1,222,358 | 0% | held |
| 47 | IMTX IMMATICS NV | Healthcare | 0.5% | $2.0m | 235,000 | -4% | reduced |
| 48 | ALLO ALLOGENE THERAPEUTICS INC | Healthcare | 0.4% | $1.7m | 1,380,118 | 0% | held |
| 49 | VKTX VIKING THERAPEUTICS INC | Healthcare | 0.4% | $1.7m | 64,516 | 0% | held |
| 50 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 0.4% | $1.7m | 218,255 | 0% | held |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.